Linked from

The 54 pages that link to Rheumatoid arthritis, each with the reason it gives.

• AutoimmunityBroader topic: It shows how persistent self-directed inflammation can damage joint tissue.

• OsteoarthritisCompared with: Unlike typical osteoarthritis, it is a systemic inflammatory disease that often affects joints symmetrically.

• GoutCompared with: Its usual persistent, symmetric pattern differs from gout’s often sudden, episodic attacks.

• PsoriasisCompared with: It can resemble psoriatic arthritis but usually lacks psoriasis-related features.

• MethotrexateRelated: Low-dose weekly methotrexate is a standard disease-modifying treatment.

• RituximabBroader topic: Rituximab can reduce disease activity by depleting B cells in selected patients.

• Systemic lupus erythematosusCompared with: Joint pain occurs in both diseases, but SLE more characteristically combines arthritis with multisystem manifestations.

• PrednisoneRelated: Prednisone can rapidly control inflammation while longer-term treatments take effect.

• Autoimmune diseaseBroader topic: It illustrates systemic autoimmunity with persistent inflammation and progressive joint damage.

• FibromyalgiaCompared with: Unlike fibromyalgia, it produces objective inflammatory joint findings and can damage joints.

• Interleukin 6Related: IL-6 contributes to inflammation and systemic symptoms in this disease.

• Carpal tunnel syndromeRelated: Wrist inflammation can reduce available space within the carpal tunnel.

• Tumor necrosis factorRelated: TNF blockade can reduce joint inflammation and damage in this disease.

• CelecoxibRelated: Celecoxib may relieve symptoms but does not stop the underlying autoimmune disease.

• Pulmonary fibrosisRelated: It can involve the lungs and cause interstitial disease with fibrosis.

• AzathioprineRelated: Azathioprine has been used as a disease-modifying treatment, though other therapies are now often preferred.

• Psoriatic arthritisCompared with: Its typically symmetric small-joint pattern contrasts with the varied patterns of psoriatic arthritis.

• Reactive arthritisCompared with: Its persistent, often symmetric pattern differs from arthritis following a discrete infection.

• Immunosuppressive therapyBroader topic: Disease-modifying immunosuppressants reduce inflammation and help prevent joint damage.

• TocilizumabRelated: Tocilizumab is used when rheumatoid arthritis remains active despite other treatments.

• DiclofenacRelated: Diclofenac can reduce its pain and inflammation but does not stop the underlying disease process.

• Disease-modifying antirheumatic drugBroader topic: DMARD treatment is central to limiting irreversible damage in this disease.

• Erythrocyte sedimentation rateRelated: ESR can help track inflammatory activity, though it cannot diagnose rheumatoid arthritis by itself.

• Polymyalgia rheumaticaCompared with: It can mimic polymyalgia rheumatica, but small-joint swelling and persistent synovitis suggest rheumatoid arthritis.

• Ankylosing spondylitisCompared with: Its usual joint distribution differs from the predominantly axial pattern here.

• ArthritisBroader topic: It illustrates how persistent immune attack can erode joint structures.

• Metacarpophalangeal jointRelated: It commonly inflames the metacarpophalangeal joints and can deform the fingers.

• InfliximabRelated: Infliximab is used with methotrexate to reduce disease activity and joint damage.

• NaproxenRelated: Naproxen can reduce symptoms, though it does not stop the underlying disease process.

• RheumatologyBroader topic: It is a defining inflammatory arthritis managed by rheumatologists.

• Systemic sclerosisCompared with: Joint inflammation dominates rheumatoid arthritis, whereas vascular injury and fibrosis define systemic sclerosis.

• Trigger fingerRelated: Inflammatory tendon-sheath disease can contribute to catching and finger dysfunction.

• ChloroquineRelated: Chloroquine has been used as a disease-modifying treatment, though safer alternatives are often favored.

• CortisoneRelated: Corticosteroids can temporarily control inflammation during active disease.

• Immunosuppressive drugBroader topic: Disease-modifying immunosuppressants help control its inflammation and joint damage.

• BetamethasoneRelated: Systemic glucocorticoids such as betamethasone may be used in selected cases to control inflammation.

• Edward Calvin KendallRelated: Early cortisone treatment produced striking improvements in patients with this disease.

• James CoburnRelated: Coburn lived with rheumatoid arthritis for decades and spoke publicly about its effects.

• Kathleen TurnerRelated: Turner has spoken publicly about performing through the disease and its treatment.

• MethylprednisoloneRelated: Methylprednisolone may reduce inflammation during severe flares or as bridging treatment.

• PrednisoloneRelated: Prednisolone may provide short-term control while longer-term therapies take effect.

• Adult-onset Still's diseaseCompared with: Both diseases can cause inflammatory arthritis, but Still's disease is distinguished by recurring fever and rash.

• ArthropathyBroader topic: It exemplifies an immune-mediated arthropathy that can erode joints over time.

• Bronchiolitis obliteransRelated: This autoimmune disease is among the conditions associated with bronchiolitis obliterans.

• Heberden's nodeCompared with: Its inflammatory finger-joint patterns differ from the bony distal enlargements typical of Heberden's nodes.

• MeloxicamRelated: Meloxicam can relieve joint symptoms but does not stop the underlying autoimmune disease.

• SulfasalazineBroader topic: Sulfasalazine is used as a disease-modifying antirheumatic drug for this condition.

• CiclosporinRelated: Ciclosporin has been used as a disease-modifying treatment, though other drugs are now often preferred.

• Connective tissue cellsRelated: Synovial fibroblasts and immune cells sustain inflammation and tissue destruction in affected joints.

• IndometacinRelated: Indometacin can ease its symptoms but does not stop the underlying immune damage.